Christina and Jackson Agar, now on an obesity drug, have altered their eating habits, throwing away leftover pizza for the first time. Both have lost about 20 pounds in six weeks, primarily using a compounded version of tirzepatide due to their insurance not covering Eli Lilly's Zepbound. This medication has dramatically improved their quality of life, but the FDA's recent declaration of the Zepbound shortage as over will soon end availability of compounded versions, leaving patients worried and confused.
They've each lost about 20 pounds in six weeks. But the Agars, who live in Minnesota, aren't taking Eli Lilly's Zepbound; their insurance doesn't cover it.
The FDA says compounding pharmacies have to stop making tirzepatide because the agency declared the yearlong Zepbound shortage over.
It is completely life-changing to take a bite of these triggering foods and just be like, enjoy it, say, 'Yup, that was good and now I'm full.'
In Arizona, Margot Carmichael was in denial. I thought what I think a lot of people perhaps did: Oh, it'll be fine.
Collection
[
|
...
]